HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY WWTR1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-WWTR1.
WWTR1 / TAZ Antibody (clone OTI1H9)
Primary AntibodyLSBio Guarantee
| Antibody: | Mouse Monoclonal |
| Applications: | Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot |
| Reactivity: | Human |
| Format: | Liquid |
$443.00each
Catalog Number: LS-C173295-100
Catalog Number: LS-C173295
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- TAZ antibody LS-C173295 is an unconjugated mouse monoclonal antibody to human TAZ (WWTR1). Validated for IHC and WB. Cited in 5 publications.
- Application
- IHC, IHC-P, WB
- Reactivity
- Hu
- Intended Use
- RUO
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Monoclonal Antibodies
- Alternative Names
- WWTR1
- Recommended Dilution: IHC-P
- 1:150
- Recommended Dilution: WB
- 1:2000
- UniProt Number
- Q9GZV5
- NCBI GenBank
- NM_015472, NP_056287.1
- SwissProt
- Q9GZV5
Target
- Target
- Human WWTR1 / TAZ
- Antigen Species
- Hu
- Epitope
- Human WWTR1
- Gene Name
- WWTR1
Antibody
- Host Species
- Ms
- Clonality
- Monoclonal
- Clone
- OTI1H9
- Isotype
- IgG2a
Immunogen
- Immunogen
- Full length human recombinant protein of human WWTR1(NP_057287) produced in HEK293T cell.
- Immunogen Type
- FL-RP
Format
- Conjugate/Label
- Unconj
- Format
- Liquid
- Formulation
- PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol, 1% BSA
- Concentration
- 1 mg/mL
- Volume
- 100 Microliter
- Preservative
- Yes
- Purification Method
- Prot A/G
Storage & Handling
- Storage Conditions
- Store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
TAZ and YAP are frequently activated oncoproteins in sarcomas. Fullenkamp CA, Hall SL, Jaber OI, Pakalniskis BL, Savage EC, Savage JM, Ofori-Amanfo GK, Lambertz AM, Ivins SD, Stipp CS, Miller BJ, Milhem MM, Tanas MR. Oncotarget. 2016;7:30094-108. PubMed: 27129148 PMC: PMC5058666